Cargando…
The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment
INTRODUCTION: Significant teratogenic effects have been demonstrated in all animal species exposed to ribavirin. Ribavirin is prescribed for chronic hepatitis C and is contraindicated in women who are pregnant and in the male sexual partners of women who are pregnant. Both sexes are advised to avoid...
Autores principales: | Sinclair, Susan M., Jones, Judith K., Miller, Richard K., Greene, Michael F., Kwo, Paul Y., Maddrey, Willis C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100215/ https://www.ncbi.nlm.nih.gov/pubmed/28689333 http://dx.doi.org/10.1007/s40264-017-0566-6 |
Ejemplares similares
-
Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry
por: Juliao, Patricia, et al.
Publicado: (2022) -
Neurological teratogenic effects of antiepileptic drugs during pregnancy
por: Nie, Qingmei, et al.
Publicado: (2016) -
COVID-19 pregnancy prevention guidance on teratogenic drugs
Publicado: (2020) -
Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies†
por: Lagan, Briege M, et al.
Publicado: (2014) -
Teratogenicity and hyperprolactinemia
por: Andrade, Chittaranjan
Publicado: (2009)